Herpes zoster vaccination coverage and factors associated among adults aged 40 and older in China: A population-based
Yiqi Xia1, Wenhui Zhu1, Zhenyu Shi2
1School of Public Health, Peking University, Beijing, China; China Centre for Health Development Studies, Peking University, Beijing, China.
Objectives:
Herpes zoster (HZ) is a significant public health issue in China, especially with an aging population and rising incidence. While vaccination effectively prevents HZ and its complications, national data on HZ vaccine (HZV) coverage and associated factors in China are limited.
Methods:
We conducted a nationwide survey across 25 provinces in mainland China, including 14,315 participants aged over 40 years, to estimate HZV uptake and associated factors among adults aged 40 years and older. Multivariate logistic regression was used to assess characteristics linked to vaccination, and we analysed vaccine types and dose completion rates.
Results:
The HZV uptake rate was 0.79 %. Vaccination was more likely among individuals with middle school education and higher household income. Most vaccinated individuals received the zoster vaccine live (ZVL) rather than the recombinant zoster vaccine (RZV), and nearly half completed two doses.
Conclusions:
HZV coverage in China is low, underscoring the need for targeted public health strategies to improve vaccine accessibility and awareness, particularly among at-risk groups, to reduce HZ-related burdens.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
10:01Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
Related Concept Videos
01:51Vaccinations
00:36Viral Mutations
00:57Viral Recombination
00:42Cross-reactivity